Vahid Reza Ostovan

Dr. Vahid Reza Ostovan


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2020 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
NFNima Fadakar
Nima Fadakar
SGSara Ghaemmaghami
Sara Ghaemmaghami
SMSeyed Masoom Masoompour
Seyed Masoom Masoompour
BYBabak Shirazi Yeganeh
Babak Shirazi Yeganeh
AAAli Akbari
Ali Akbari
VOVahid Reza Ostovan
Vahid Reza Ostovan

6 July 2022 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
VOVahid Reza Ostovan
Vahid Reza Ostovan
MSMohammad Ali Sahraian
Mohammad Ali Sahraian
NKNeda Karazhian
Neda Karazhian
MRMahtab Rostamihosseinkhani
Mahtab Rostamihosseinkhani
MSMarzieh Salimi
Marzieh Salimi
HMHoda Marbooti
Hoda Marbooti

3 August 2021 in Journal of NeuroVirology
Verified
Journal Article
Open access
PDF file
VOVahid Reza Ostovan
Vahid Reza Ostovan
SRShirin Rezapanah
Shirin Rezapanah
ZBZahra Behzadi
Zahra Behzadi
LHLeila Hosseini
Leila Hosseini
RJReza Jahangiri
Reza Jahangiri
MRMahtab Rostami
Mahtab Rostami
Among the ever-increasing literature of the coronavirus disease 2019 (COVID-19), there have been reports on several complications in association with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), such as secondary bacterial and fungal infections. We report a 61-year-old woman with a past history of diabetes mellitus who presented to our hospital suffering from COVID-19 infection. During the course of her hospitalization, the patient developed chemosis and proptosis in both eyes, ultimately leading to a diagnosis of invasive rhino-orbital-cerebral mucormycosis and cerebrovascular thrombosis. This study strengthens the possible association between the occurrence of COVID-19 and invasive mucormycosis infection, providing new impetus for further investigations to substantiate this correlation.

11 August 2022 in Current Fungal Infection Reports
Verified
Journal Article
Closed access
PDF file
VOVahid Reza Ostovan
Vahid Reza Ostovan
RTReza Tabrizi
Reza Tabrizi
HBHanieh Bazrafshan
Hanieh Bazrafshan
ZBZahra Bahrami
Zahra Bahrami
HKHajar Khazraei
Hajar Khazraei
MGMatthew Grant
Matthew Grant

22 December 2020 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
Parham HabibzadehParham Habibzadeh
Parham Habibzadeh
ZTZahra Tabatabaei
Zahra Tabatabaei
SISoroor Inaloo
Soroor Inaloo
MNMuhammad Mahdi Nashatizadeh
Muhammad Mahdi Nashatizadeh
MSMatthis Synofzik
Matthis Synofzik
MFMohammad Faghihi
Mohammad Faghihi
Autosomal recessive spastic ataxia of Charlevoix–Saguenay (ARSACS) is a rare neurodegenerative disorder caused by biallelic mutations in the SACS gene. Once thought to be limited to Charlevoix–Saguenay region of Quebec, recent evidence has indicated that this disorder is present worldwide. It is classically characterized by the triad of ataxia, pyramidal involvement, and axonal-demyelinating sensorimotor neuropathy. However, diverse clinical features have been reported to be associated with this disorder. In this report, we present the first Iranian family affected by ARSACS with unique clinical features (mirror movements, hypokinesia/bradykinesia, and rigidity) harboring a novel deletion mutation in the SACS gene. Our findings expand the genetic and phenotypic spectrum of this disorder.

25 March 2022 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Open access
MGMaryam Vasaghi Gharamaleki
Maryam Vasaghi Gharamaleki
MHMaryam Habibagahi
Maryam Habibagahi
Etrat HooshmandiEtrat Hooshmandi
Etrat Hooshmandi
RTReza Tabrizi
Reza Tabrizi
SAShahram Arsang-Jang
Shahram Arsang-Jang
ABAfshin Borhani-Haghighi
Afshin Borhani-Haghighi
There are several reports of the association between SARS-CoV-2 infection (COVID-19) and cerebral venous sinus thrombosis (CVST). In this study, we aimed to compare the hospitalization rate of CVST before and during the COVID-19 pandemic (before vaccination program). In this retrospective cohort study, the hospitalization rate of adult CVST patients in Namazi hospital, a tertiary referral center in the south of Iran, was compared in two periods of time. We defined March 2018 to March 2019 as the pre-COVID-19 period and March 2020 to March 2021 as the COVID-19 period. 50 and 77 adult CVST patients were hospitalized in the pre-COVID-19 and COVID-19 periods, respectively. The crude CVST hospitalization rate increased from 14.33 in the pre-COVID-19 period to 21.7 per million in the COVID-19 era (P = 0.021). However, after age and sex adjustment, the incremental trend in hospitalization rate was not significant (95% CrI: -2.2, 5.14). Patients > 50-year-old were more often hospitalized in the COVID-19 period (P = 0.042). SARS-CoV-2 PCR test was done in 49.3% out of all COVID-19 period patients, which were positive in 6.5%. Modified Rankin Scale (mRS) score ≥3 at three-month follow-up was associated with age (P = 0.015) and malignancy (P = 0.014) in pre-COVID period; and was associated with age (P = 0.025), altered mental status on admission time (P<0.001), malignancy (P = 0.041) and COVID-19 infection (P = 0.008) in COVID-19 period. Since there was a more dismal outcome in COVID-19 associated CVST, a high index of suspicion for CVST among COVID-19 positive is recommended.